Latest filing published 07 Jun 2018 for aTYR PHARMA INC.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +60.4%Entry US$33.60 · Close at T+365 US$53.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ashraf Amanullah: trading record in brief
Ashraf Amanullah is a declared insider of aTYR PHARMA Inc, with filings sourced from SEC (Form 4). The record holds 4 filings, for trades running from 20 December 2016 to 31 May 2018.
Market trades split into 1 purchase (€24k) and 1 sale (€3,886). Purchases outweigh sales by €20k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 option exercises. Since January 2018: no purchases and 1 sale on the market.
The newest entry dates from 7 June 2018: an option exercise, in aTYR PHARMA Inc. The most recent open-market purchase was published on 21 December 2016, 3,610 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ashraf Amanullah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,333 shares0Common StockSEC:0001209191-18-036511:0
- 3,334 shares0Common StockSEC:0001209191-18-008609:0
- 1,402 shares@ US$3.4014.0% of flowCommon StockSEC:0001209191-18-008609:1
- 11,000 shares@ US$2.2586.0% of flowCommon StockSEC:0001209191-16-156372:0Canonical exit: 20 Mar 2017 (T+90)
4 of 4 declarations